Top Institutions in Ophthalmology and Gene Therapy
Leading institutions conduct translational research and clinical trials involving gene replacement therapies, optogenetic techniques, and neurotrophic factor delivery systems, leveraging advanced molecular biology, viral vector development, and retinal cell biology expertise to develop and evaluate novel treatments.
-
#1
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is a global leader in ocular gene therapy and optogenetics research, with pioneering clinical trials including early development of Luxturna and ongoing optogenetic therapy trials for advanced retinal diseases.
-
#2
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
The University of Pennsylvania has been instrumental in developing adeno-associated virus (AAV) vector technology and advancing gene therapy for retinal diseases, with significant contributions to optogenetic approaches and clinical translation.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its comprehensive retinal disease programs and has contributed extensively to gene therapy clinical trials and optogenetic research aimed at restoring vision in inherited retinal degenerations.
-
#4
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is a leading center for retinal disease treatment and research, with active involvement in gene therapy trials and emerging optogenetic therapies for inherited retinal diseases.
-
#5
University of California, San Francisco (UCSF) School of Medicine
San Francisco, CA
UCSF has a robust gene therapy research program with a focus on retinal diseases and is advancing optogenetic approaches through both preclinical and clinical studies.